跳至主要内容
临床试验/NCT04475822
NCT04475822已完成不适用

An Intervention Study of Intermittent Fasting and Low Carbon Diet in Patients With Metabolic Syndrome

First Affiliated Hospital Xi'an Jiaotong University1 个研究点 分布在 1 个国家目标入组 169 人开始时间: 2020年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
169
试验地点
1
主要终点
weight

研究概览

简要总结

The prevalence of metabolic syndrome (MetS) is increasing all over the world, which is largely related to the increasing obesity population and the current inactive lifestyle of human beings. It is a common problem facing public health and clinical practice.Metabolic syndrome is an accumulation of biologically metabolic risk factors related to cardiovascular disease and diabetes, including glucose metabolism disorders, hypertension, dyslipidemia, and obesity (especially central obesity).Researchers believe that the common pathological basis of these manifestations is insulin resistance, which is generally considered to be a reduction in the biological effects of insulin compared with the normal biological effects of expected biological phenomena.Nowadays, there are more and more studies on insulin resistance in the world. We have known that age, poor living and eating habits, high blood fat, high blood sugar and stress all lead to insulin resistance.

The researchers hope to reduce weight, reduce body fat rate, improve body fat distribution and insulin resistance, reverse abnormal metabolic indicators, and ultimately reduce the incidence of chronic diseases in patients with metabolic syndrome through the intervention of lifestyle and diet habits in the early stage of the disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

weight

时间窗: Three months after the intervention

kg

body fat

时间窗: Three months after the intervention

次要结局

  • blood pressure(Three months after the intervention)
  • blood glucose(Three months after the intervention)
  • uric acid(Three months after the intervention)
  • blood lipid(Three months after the intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验